查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1480366

到 2033 年免疫診斷的全球市場機會與策略

Immunodiagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 296 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年全球免疫診斷市場價值為146.464億美元，到2023年複合年成長率將超過7.0%。

醫療支出增加

醫療保健支出的成長推動了業績期間免疫診斷市場的擴張。衛生支出對於推動創新和改善先進技術的取得至關重要。隨著醫療保健預算的增加，對先進診斷技術（包括免疫診斷）的需求激增，這些技術在疾病檢測和監測中發揮著至關重要的作用。支出的增加使醫療機構能夠投資最先進的設備和創新的診斷解決方案，從而推動市場成長。根據管理醫療保險和醫療補助等美國主要醫療保健計劃的美國聯邦機構醫療保險和醫療補助服務中心的數據，2020 年美國醫療保健支出成長 9.7%，達到 4.1 兆美元1，相當於每人 12,530 美元。 2020 年，英國醫療保健支出佔國內生產總值(GDP) 的比例為 19.7%，即 2,690 億英鎊（3,544.5 億美元），比 2019 年支出名目增加 20%。因此，醫療保健支出的增加推動了免疫診斷市場的成長。

目錄

第1章執行摘要

  • 免疫診斷 - 市場吸引力和宏觀經濟條件

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特點

  • 一般市場定義
  • 概述
  • 免疫診斷市場定義與細分
  • 按產品細分市場
    • 試劑及耗材
    • 裝置
    • 軟體和服務
  • 市場區隔：按技術
    • 酵素免疫分析法
    • 化學冷光免疫檢測
    • 螢光免疫分析法
    • 免疫檢測
    • 快速診斷
    • 其他
  • 市場區隔：按應用
    • 感染疾病
    • 腫瘤學和內分泌學
    • 骨骼和礦物質疾病
    • 自體免疫疾病
    • 心臟生物標記
    • 肝炎和逆轉錄病毒檢測
    • 其他
  • 市場區隔：按最終用戶
    • 醫院
    • 診所
    • 診斷實驗室
    • 學術研究所
    • 其他

第7章 主要市場趨勢

  • 採用照護現場免疫診斷來提供快速結果
  • 利用 DNA 擴增技術提高免疫檢測靈敏度
  • 市場參與企業之間的策略夥伴關係

第8章免疫診斷市場：宏觀經濟情景

  • COVID-19 的影響：免疫診斷市場
  • 烏克蘭戰爭的影響：免疫診斷市場
  • 高通膨的影響：免疫診斷市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 市場促進因素，2018-2023
    • 市場限制，2018-2023
  • 2023-2028 年、2033 年市場成長預測
    • 2023-2028 年市場促進因素
    • 市場限制，2023-2028

第10章全球免疫診斷市場：細分

  • 全球免疫診斷市場：按產品、性能和預測，2018-2023、2028、2033
  • 全球免疫診斷市場：按應用、效能和預測，2018-2023、2028、2033
  • 全球免疫診斷市場：最終用戶的表現和預測，2018-2023、2028、2033
  • 全球免疫診斷市場：依技術分類的表現與預測，2018-2023、2028、2033

第11章免疫診斷市場：區域/國家分析

  • 全球免疫診斷市場：按地區、績效和預測，2018-2023、2028、2033
  • 全球免疫診斷市場：依國家、績效及預測，2018-2023、2028、2033

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • Abbott Laboratories
  • F. Hoffman-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • DiaSorin SpA

第20章 競爭基準化分析

第 21 章競爭對手儀表板

第22章 重大併購

  • Novacyt Acquired Yourgene Health
  • Freenome Acquired Oncimmune Ltd.
  • DiaSorin SpA Acquired Luminex Corporation
  • Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • Heska Acquired LightDeck Diagnostics

第23章機遇與策略

  • 2028 年全球免疫診斷市場：提供新機會的國家
  • 2028 年全球免疫診斷市場：提供新機會的細分市場
  • 2028 年全球免疫診斷市場：成長策略
    • 根據市場趨勢制定策略
    • 競爭對手的策略

第24章免疫診斷市場：結論與建議

  • 結論
  • 推薦
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人力資源

第25章附錄

簡介目錄
Product Code: o&s1166

Immunodiagnostics refers to a branch of medical diagnostics that utilizes antibodies to detect diseases or conditions. This field relies on the specific interactions between antigens (substances that stimulate an immune response) and antibodies (specific binding proteins produced by immune cells in response to antigens). Immunodiagnostic tests can identify the presence of antigens produced by pathogens such as viruses, bacteria or parasites, as well as detect proteins produced by the body in response to pathogens or pathological changes in organs, tissues and cells in response to disease or injury.

The immunodiagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of immunodiagnostics products and services that utilize the antibodies to detect and measure specific substances through antigen-antibody reactions.

The global immunodiagnostics market was valued at $14,646.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 7.0%.

Rise In Healthcare Expenditure

The rise in healthcare expenditure drove the expansion of the immunodiagnostics market during the historic period. Healthcare expenditure is essential for driving innovation and improving access to advanced technologies. As healthcare budgets increased, there was a corresponding surge in demand for advanced diagnostic technologies, including immunodiagnostics, which played a pivotal role in disease detection and monitoring. This increased expenditure allowed healthcare facilities to invest in state-of-the-art equipment and innovative diagnostic solutions, driving market growth. According to the Centers for Medicare & Medicaid Services, a US-based federal agency that administers the nation's major healthcare programs including Medicare and Medicaid, health spending in the USA grew by 9.7% in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7% of GDP in the UK in 2020, which is £269 billion ($354.45 billion), a nominal-terms increase of 20% on spending in 2019. Therefore, the rise in healthcare expenditure propelled the growth of the immunodiagnostics market.

Increasing Immunoassay Sensitivity Using DNA Amplification Technology

Companies operating in immunodiagnostics are increasing immunoassay sensitivity using DNA amplification technology. This approach involves amplifying target DNA sequences associated with specific biomarkers, thereby increasing the detectability of analytes in biological samples. By integrating DNA amplification techniques such as polymerase chain reaction (PCR), into immunoassay platforms, companies can achieve greater sensitivity and accuracy in detecting low-concentration analytes. For instance, in May 2021, Cavidi, a Sweden-based pharmaceutical and diagnostic company, introduced a groundbreaking platform technology called Exazym, signal generating technology to bring ultra-sensitive detection-levels to conventional immunodiagnostic assays. This innovative technology offers a novel signal amplification method known as Binding Oligo Ladder Detection (BOLD), which significantly enhances immunoassay signal amplification by up to 100 times.

The global immunodiagnostics market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 23.25% of the total market in 2022.

Immunodiagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunodiagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for immunodiagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunodiagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunodiagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for immunodiagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Reagents And Consumables; Instruments; Software And Services
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Hepatitis And Retrovirus Testing; Other Applications
  • 4) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End-Users
  • Companies Mentioned: Abbott Laboratories;F. Hoffmann-La Roche Ltd;Thermo Fisher Scientific Inc.; Danaher Corporation; DiaSorin S.p.A.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunodiagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Immunodiagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Immunodiagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Reagents And Consumables
    • 6.4.2 Instruments
    • 6.4.3 Software And Services
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Enzyme-Linked Immunosorbent Assay
    • 6.5.2 Chemiluminescence Immunoassay
    • 6.5.3 Fluorescent Immunoassay
    • 6.5.4 Radioimmunoassay
    • 6.5.5 Rapid Test
    • 6.5.6 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Infectious Diseases
    • 6.6.2 Oncology And Endocrinology
    • 6.6.3 Bone And Mineral Diseases
    • 6.6.4 Autoimmune Disorders
    • 6.6.5 Cardiac Biomarkers
    • 6.6.6 Hepatitis And Retrovirus Testing
    • 6.6.7 Other Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Clinics
    • 6.7.3 Diagnostic Laboratories
    • 6.7.4 Academic And Research Institutes
    • 6.7.5 Other End Users

7 Major Market Trends

  • 7.1 Introduction Of Point-Of-Care Immunodiagnostics To Provide Rapid Results
  • 7.2 Increasing Immunoassay Sensitivity Using DNA Amplification Technology
  • 7.3 Strategic Partnership Among Market Players

8 Immunodiagnostics Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Immunodiagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Immunodiagnostics Market
  • 8.3 Impact Of High Inflation On The Immunodiagnostics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Immunodiagnostics Market Segmentation

  • 10.1 Global Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Immunodiagnostics Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Immunodiagnostics Market, Regional and Country Analysis

  • 11.1 Global Immunodiagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Immunodiagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Immunodiagnostics Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Taxes Levied
    • 12.9.6 Regulations
    • 12.9.7 Regulatory Bodies
    • 12.9.8 Major Associations
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Immunodiagnostics Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Immunodiagnostics Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Immunodiagnostics Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investment
    • 16.2.11 Major Companies
  • 16.3 South America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Immunodiagnostics Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Abbott Laboratories
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Thermo Fisher Scientific Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Danaher Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 DiaSorin S.p.A.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Novacyt Acquired Yourgene Health
  • 22.2 Freenome Acquired Oncimmune Ltd.
  • 22.3 DiaSorin S.p.A Acquired Luminex Corporation
  • 22.4 Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • 22.5 Heska Acquired LightDeck Diagnostics

23 Opportunities And Strategies

  • 23.1 Global Immunodiagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Immunodiagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Immunodiagnostics Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Immunodiagnostics Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer